Original Research

Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation

Ottoboni T, Keller MR, Cravets M, Clendeninn N, Quart B

Drug Design, Development and Therapy 2018, 12:429-435

Published Date: 1 March 2018